19.75 +0.61 (3.15%)
PODD
| Trade PODD now with |
|
Stock Details
Last Trade:19.75 Change:+0.61 (3.15%) Prev Close:19.14 Open: 19.36 Days Range:19.30 – 19.81 52 Week Range: 14.00 - 23.33 Volume:194130 P/E: N/AEPS:-1.43
View AllRecent Alerts 02/09/12
Recent Alert on 02/07/12 at 8:39am
Canaccord Genuity on Life Sciences/Biomedical Devices and Services: Take on Q4 and Beyond
Canaccord Genuity on Life Sciences/Biomedical Devices and Services: Take on Q4 and Beyond
Canaccord Genuity on Life Sciences/Biomedical Devices and Services: Dynamics of the diabetes industry into 2012: our take on Q4/11 and beyond Analyst, William J. Plovanic, said, "Heading into the Q4/11 earnings season for diabetes technology and... Read More
Recent Alert on 01/17/12 at 11:27am
Notable Analyst Rating Changes 01/17: (TSLA) (WYNN) (AMAT) Upgraded; (INTC) (PM) (RYL) Downgraded
Notable Analyst Rating Changes 01/17: (TSLA) (WYNN) (AMAT) Upgraded; (INTC) (PM) (RYL) Downgraded
Recent Alert on 01/17/12 at 7:08am
Brean Murray Carret & Co. Starts Insulet Corporation (PODD) at Buy; Attractive Growth Story With Key Approval Near Term
Brean Murray Carret & Co. Starts Insulet Corporation (PODD) at Buy; Attractive Growth Story With Key Approval Near Term
Recent Alert on 12/07/11 at 10:18am
Highlights From Canaccord Genuity Cardiovascular, Aesthestics & Metabolic Disorders Conference Part II
Highlights From Canaccord Genuity Cardiovascular, Aesthestics & Metabolic Disorders Conference Part II
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 01/06/12 at 1:19pm
Pure Play Diabetes Technology Companies Offer Little To No Value For Investor
Pure Play Diabetes Technology Companies Offer Little To No Value For Investor